Black Diamond Therapeutics (BDTX) Operating Income (QoQ) (2019 - 2026)
Black Diamond Therapeutics (BDTX) Operating Income (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.06% |
| Dec 31, 2025 | -60.41% |
| Sep 30, 2025 | 18.20% |
| Jun 30, 2025 | -124.61% |
| Mar 31, 2025 | 398.39% |
| Dec 31, 2024 | -0.80% |
| Sep 30, 2024 | 18.08% |
| Jun 30, 2024 | -9.31% |
| Mar 31, 2024 | 2.92% |
| Dec 31, 2023 | 13.15% |
| Sep 30, 2023 | -19.87% |
| Jun 30, 2023 | 7.09% |
| Mar 31, 2023 | 1.33% |
| Dec 31, 2022 | 1.23% |
| Sep 30, 2022 | 4.53% |
| Jun 30, 2022 | 9.76% |
| Mar 31, 2022 | 1.54% |
| Dec 31, 2021 | 26.25% |
| Sep 30, 2021 | -1.87% |
| Jun 30, 2021 | -13.03% |